Loading…

Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects

Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to f...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2021-08, Vol.12, p.707491-707491
Main Authors: Wu, Xianbo, Huang, Jianli, Wang, Jie, Xu, Yihua, Yang, Xinwei, Sun, Minghan, Shi, Jianyou
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3
cites cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3
container_end_page 707491
container_issue
container_start_page 707491
container_title Frontiers in pharmacology
container_volume 12
creator Wu, Xianbo
Huang, Jianli
Wang, Jie
Xu, Yihua
Yang, Xinwei
Sun, Minghan
Shi, Jianyou
description Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.
doi_str_mv 10.3389/fphar.2021.707491
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_62db3c08b0744db79253fda703cbc838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_62db3c08b0744db79253fda703cbc838</doaj_id><sourcerecordid>2570114417</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</originalsourceid><addsrcrecordid>eNpVks9u3CAQxq2qVROleYDeOPbiLf_W4B4qRatuEylR97B3hIdxlsg2LuBIeYE8d9lsVCUcYMQ38wOGr6q-MroSQrff-_lg44pTzlaKKtmyD9U5axpRt5rxj2_is-oypQdahmhb0cjP1ZmQUreK0vPq-W4Zsq93hTVawCV7sAO5guwfffaYSOjJ5uAnTEiuMXZF3IXhKVmAUuJdyfATyQck-4g2jzjlY8luGcYw2fhEtr6LIfn0g2zCBDhnYidHtkteIpJdkWaEnL5Un3o7JLx8XS-q_fbXfnNd3_75fbO5uq1BSp5rpyVHbnvXM9UoWyYGmmqQXcMa1vEeqEULDWqNQrl27fqOo6IAaq1aFBfVzQnrgn0wc_RjuaIJ1puXjRDvjY2lBQOahrtOANVd6a10nWr5WvTOKiqgAy10Yf08sealG9FBeXm0wzvoe2XyB3MfHo2WrPwKL4Bvr4AY_i6Yshl9AhwGO2FYkuFrRRmTkqmSyk6pUBqWIvb_j2HUHN1gXtxgjm4wJzeIf5NBqzA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570114417</pqid></control><display><type>article</type><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><source>PubMed Central</source><creator>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</creator><creatorcontrib>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</creatorcontrib><description>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2021.707491</identifier><identifier>PMID: 34489700</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>collagen-1 ; extracellular matrix ; Pharmacology ; polysaccharide ; pulmonary fibrosis ; traditional Chinese medicine ; transforming growth factor-β</subject><ispartof>Frontiers in pharmacology, 2021-08, Vol.12, p.707491-707491</ispartof><rights>Copyright © 2021 Wu, Huang, Wang, Xu, Yang, Sun and Shi. 2021 Wu, Huang, Wang, Xu, Yang, Sun and Shi</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</citedby><cites>FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418122/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418122/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Wu, Xianbo</creatorcontrib><creatorcontrib>Huang, Jianli</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><creatorcontrib>Xu, Yihua</creatorcontrib><creatorcontrib>Yang, Xinwei</creatorcontrib><creatorcontrib>Sun, Minghan</creatorcontrib><creatorcontrib>Shi, Jianyou</creatorcontrib><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><title>Frontiers in pharmacology</title><description>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</description><subject>collagen-1</subject><subject>extracellular matrix</subject><subject>Pharmacology</subject><subject>polysaccharide</subject><subject>pulmonary fibrosis</subject><subject>traditional Chinese medicine</subject><subject>transforming growth factor-β</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks9u3CAQxq2qVROleYDeOPbiLf_W4B4qRatuEylR97B3hIdxlsg2LuBIeYE8d9lsVCUcYMQ38wOGr6q-MroSQrff-_lg44pTzlaKKtmyD9U5axpRt5rxj2_is-oypQdahmhb0cjP1ZmQUreK0vPq-W4Zsq93hTVawCV7sAO5guwfffaYSOjJ5uAnTEiuMXZF3IXhKVmAUuJdyfATyQck-4g2jzjlY8luGcYw2fhEtr6LIfn0g2zCBDhnYidHtkteIpJdkWaEnL5Un3o7JLx8XS-q_fbXfnNd3_75fbO5uq1BSp5rpyVHbnvXM9UoWyYGmmqQXcMa1vEeqEULDWqNQrl27fqOo6IAaq1aFBfVzQnrgn0wc_RjuaIJ1puXjRDvjY2lBQOahrtOANVd6a10nWr5WvTOKiqgAy10Yf08sealG9FBeXm0wzvoe2XyB3MfHo2WrPwKL4Bvr4AY_i6Yshl9AhwGO2FYkuFrRRmTkqmSyk6pUBqWIvb_j2HUHN1gXtxgjm4wJzeIf5NBqzA</recordid><startdate>20210817</startdate><enddate>20210817</enddate><creator>Wu, Xianbo</creator><creator>Huang, Jianli</creator><creator>Wang, Jie</creator><creator>Xu, Yihua</creator><creator>Yang, Xinwei</creator><creator>Sun, Minghan</creator><creator>Shi, Jianyou</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210817</creationdate><title>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</title><author>Wu, Xianbo ; Huang, Jianli ; Wang, Jie ; Xu, Yihua ; Yang, Xinwei ; Sun, Minghan ; Shi, Jianyou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>collagen-1</topic><topic>extracellular matrix</topic><topic>Pharmacology</topic><topic>polysaccharide</topic><topic>pulmonary fibrosis</topic><topic>traditional Chinese medicine</topic><topic>transforming growth factor-β</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Xianbo</creatorcontrib><creatorcontrib>Huang, Jianli</creatorcontrib><creatorcontrib>Wang, Jie</creatorcontrib><creatorcontrib>Xu, Yihua</creatorcontrib><creatorcontrib>Yang, Xinwei</creatorcontrib><creatorcontrib>Sun, Minghan</creatorcontrib><creatorcontrib>Shi, Jianyou</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Xianbo</au><au>Huang, Jianli</au><au>Wang, Jie</au><au>Xu, Yihua</au><au>Yang, Xinwei</au><au>Sun, Minghan</au><au>Shi, Jianyou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2021-08-17</date><risdate>2021</risdate><volume>12</volume><spage>707491</spage><epage>707491</epage><pages>707491-707491</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Pulmonary fibrosis is a fatal chronic progressive respiratory disease, characterized by continuous scarring of the lung parenchyma, leading to respiratory failure and death. The incidence of PF has increased over time. There are drugs, yet, there are some limitations. Hence, it is of importance to find new therapies and new drugs to replace the treatment of pulmonary fibrosis. In recent years, there have been a great number of research reports on the treatment of traditional Chinese medicine polysaccharides in various system fields. Among them, the treatment of PF has also gained extensive attention. This review summarized the source of polysaccharides, the drug activity of traditional Chinese medicine, and the protective effects on targets of Pulmonary fibrosis. We hope it can inspire researchers to design and develop polysaccharides, serving as a reference for potential clinical therapeutic drugs.</abstract><pub>Frontiers Media S.A</pub><pmid>34489700</pmid><doi>10.3389/fphar.2021.707491</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2021-08, Vol.12, p.707491-707491
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_62db3c08b0744db79253fda703cbc838
source PubMed Central
subjects collagen-1
extracellular matrix
Pharmacology
polysaccharide
pulmonary fibrosis
traditional Chinese medicine
transforming growth factor-β
title Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multi-Pharmaceutical%20Activities%20of%20Chinese%20Herbal%20Polysaccharides%20in%20the%20Treatment%20of%20Pulmonary%20Fibrosis:%20Concept%20and%20Future%20Prospects&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Wu,%20Xianbo&rft.date=2021-08-17&rft.volume=12&rft.spage=707491&rft.epage=707491&rft.pages=707491-707491&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2021.707491&rft_dat=%3Cproquest_doaj_%3E2570114417%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-d842e2afdf1767a1761c808c4b6161b2fc0aeac6e88e37d95dfb2e70cc7579e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570114417&rft_id=info:pmid/34489700&rfr_iscdi=true